Evidence map›Paper›PMID 33615052›Full record

ArticleKidney international reports2021

Attitudes and Practices of Australian Nephrologists Toward Implementation of Clinical Genomics.

Kushani Jayasinghe, Catherine Quinlan, Andrew J Mallett, Peter G Kerr, Belinda McClaren, Amy Nisselle, Amali Mallawaarachchi, Kevan R Polkinghorne, Chirag Patel, Stephanie Best and 1 more

Open access · goldAbstract read
In one paragraph

Article in Kidney international reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Contextual factors of implementing APOL1 genetic testing into living kidney donor clinical evaluation.Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Patient outcomes and clinician perspectives following one year ofTranslational breast cancer research : a journal focusing on translational research in breast cancer · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. The Role of Genetic Testing in Adult CKD.Journal of the American Society of Nephrology : JASN · 2024
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Kushani JayasingheDepartment of Nephrology, Monash Health, Melbourne, Australia.
Catherine QuinlanKidney Regeneration, Murdoch Children's Research Institute, Melbourne, Australia.
Andrew J MallettThe KidGen Collaborative, Australian Genomics Health Alliance, Melbourne, Australia.
Peter G KerrDepartment of Nephrology, Monash Health, Melbourne, Australia.
Belinda McClarenKidney Regeneration, Murdoch Children's Research Institute, Melbourne, Australia.
Amy NisselleKidney Regeneration, Murdoch Children's Research Institute, Melbourne, Australia.
Amali MallawaarachchiThe KidGen Collaborative, Australian Genomics Health Alliance, Melbourne, Australia.
Kevan R PolkinghorneDepartment of Nephrology, Monash Health, Melbourne, Australia.
Chirag PatelThe KidGen Collaborative, Australian Genomics Health Alliance, Melbourne, Australia.
Stephanie BestAustralian Genomics Health Alliance, Melbourne, Australia.
Zornitza StarkThe KidGen Collaborative, Australian Genomics Health Alliance, Melbourne, Australia.
Melbourne Genomics Health Alliance · AUMonash Health · AUUniversity of Melbourne · AUUniversity of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionGenomic testing is becoming widely available as a diagnostic tool, although widespread implementation is not yet established in nephrology.

methodsAn anonymous electronic survey was administered to investigate experience and confidence with genomic tests, perceived clinical utility of genomic services, preferences for service delivery models, and readiness for implementation among nephrologists. Questions were guided by a comprehensive literature review and published tools, including a validated theoretical framework for implementation of genomic medicine: Consolidated Framework for Implementation Research (CFIR).

resultsResponses were received from 224 clinicians, of which 172 were eligible for analysis. Most clinicians (132 [76%]) had referred at least one patient to a genetics clinic. Despite most clinicians (136 [85%]) indicating that they believed genetic testing would be useful, only 39 (23%) indicated they felt confident to use results of genomic testing, with pediatric clinicians feeling more confident compared with adult clinicians (12 of 20 [60%] vs. 27 of 149 [18%]),

conclusionsOur findings suggest support for genomic testing among nephrologists, with a strong preference for a multidisciplinary model (involving a nephrologist, clinical geneticist, and genetic counselor). Broad-ranging interventions are urgently required to shift the current culture and ensure successful implementation of genomics in nephrology, including reducing knowledge gaps, increased funding and resources, disease-specific guidelines, and streamlining of testing processes.

Indexed as

genetic kidney diseasegenomic implementationimplementation science

Identifiers

PMID33615052
PMCPMC7879212
OpenAlexW3105574289

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.